Round Type
Venture
Investors
Description
Today, Norgine Europe B.V. ("Norgine", the "Company"), a leading European specialty pharmaceutical company, announced that the Private Equity business within Goldman Sachs Asset Management has completed its acquisition of a majority stake in the Company. The deal closure is a key milestone in Norgine's history, following over 110 years of family ownership by the Stein Family (who will continue to own a significant stake in the Company). With Goldman Sachs Asset Management as its key partner, Norgine is strongly positioned to deliver on its mission of bringing transformative medicines to market while purposefully putting patients at the heart of its strategy
Quick answer
Norgine raised an undisclosed amount in a funding round, dated December 15, 2022. Investors: Goldman Sachs Asset Management.
- How much did Norgine raise?
- Norgine raised an undisclosed amount in a funding round on December 15, 2022.
- Who invested in Norgine?
- Goldman Sachs Asset Management is named as investors in this round.
- What does Norgine do?
- Norgine is a European specialty pharmaceutical company that has strived to deliver innovative medicines to patients for over a century.
- Where is Norgine based and how big is it?
- Fundz records about 1,067 employees.
- Who are the decision-makers at Norgine?
- Fundz holds 1 contact at Norgine. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Norgine that raised within 45 days of this round, from Fundz verified event records.
- Enzene raised $50M (Funding Round) on January 29, 2023.
- Alloplex Biotherapeutics, Inc. raised $21M on January 27, 2023.
- Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
- Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
- Colossal Biosciences raised $163M on January 27, 2023.
- Avenzo Therapeutics raised $243K (Pre-Seed) on January 27, 2023.
Who to call at Norgine, and when
A new round usually means Norgine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Norgine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Norgine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Norgine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Norgine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Norgine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.